AARDEX Group, the global leader in medication adherence solutions, has today announced a collaboration agreement with Compliance Meds Technologies (CMT), a mobile-health technology solutions provider. In this cooperation, the partners will combine the AARDEX MEMS® Adherence Software with CMT’s CleverCap® … Read More
Breaking News
Innovative Approaches to Enhance and Measure Medication Adherence in Chronic Disease Management
Medication adherence is a vital component in managing chronic diseases effectively. However, it remains a significant challenge, with non-adherence rates reaching up to 50% among patients. This lack of adherence results in poor health outcomes and increased burdens on healthcare … Read More
Is the data from randomised clinical trials random to the point of pointless?
In a recent paper titled ‘The impacts of undetected nonadherence in phase II, III and post-marketing clinical trials: An overview’ the authors detailed the findings of a research project which aimed to provide an overview of the consequences of unrecognized … Read More
Clinical trial failures: Are we counting the cost of poor adherence?
Clearly it is in no one’s interests for a clinical trial to fail. Whenever these high-stake activites are abandoned and drug development pathways are aborted, missed opportunities abound. Beyond the sponsor’s missed commercial opportunity, there are missed opportunities to advance … Read More
Moving clinical trials towards the value-rich model of continuous monitoring
In a clinical trial, every piece of data contributes to the overall story being told. No matter how small or seemingly insignificant, all the information that emerges over the course of the process adds rich detail to the narrative. Two … Read More
AARDEX Group and SHL Medical forge strategic alliance to interface medication adherence software with connected self-injection solutions
AARDEX Group Belgium – SHL Medical, a world-leading provider of drug delivery devices, and AARDEX Group, the global leader in medication adherence solutions, today announced their strategic partnership aimed at delivering an end-to-end solution for pharma customers seeking to demonstrate … Read More
ESPACOMP Conference: A collective opportunity to advance the science of medication adherence
It is perhaps ironic that Alexander Graham Bell, often singled out as the individual who invented the telephone, was a man who believed in the value of collective endeavour. Indeed, Bell is quoted as saying: “Great discoveries and improvements invariably … Read More
Placebo and adherence: Is a complicated relationship compromising clinical trial effectiveness?
In 1920, The Lancet published a paper authored by T.C. Graves entitled ‘Commentary on a case of hystero-epilepsy with delayed puberty: Treated with testicular extract’. While the article was not the first to mention the placebo effect, it is recognised … Read More
Digital adherence measurement in clinical trials: The era of clearer insight is already here
Among the many forces that can influence clinical trials, arguably not enough attention is paid to status quo bias. A common phenomenon, status quo bias can explain why any proposed departure from existing expectations or dominant practice can be … Read More
Enhancing Medication Adherence in Rare Disease Clinical Trials
In observance of Rare Disease Day, it is imperative to underscore the progressive strides within the domain of rare disease research. Rare diseases, characterized by their infrequent occurrence within the general populace, impose significant burdens not only on the affected … Read More